Patents by Inventor Magdalene Moran

Magdalene Moran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130059869
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Application
    Filed: February 22, 2012
    Publication date: March 7, 2013
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • Patent number: 8163761
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: April 24, 2012
    Assignee: Hydra Biosciences, Inc.
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • Publication number: 20090143377
    Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
    Type: Application
    Filed: June 23, 2008
    Publication date: June 4, 2009
    Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
  • Publication number: 20070219222
    Abstract: The present application relates to compounds and methods for treating pain, incontinence and other conditions.
    Type: Application
    Filed: December 22, 2006
    Publication date: September 20, 2007
    Applicant: Hydra Biosciences
    Inventors: Magdalene Moran, Christopher Fanger, Jayhong Chong, Colleen McNamara, Xiaoguang Zhen, Josh Mandel-Brehm
  • Publication number: 20070213321
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: November 15, 2006
    Publication date: September 13, 2007
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Christopher Fanger, Glenn Larsen, William Lumma, Magdalene Moran, Amy Ripka, Dennis Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20070179164
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: November 3, 2006
    Publication date: August 2, 2007
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Christopher Fanger, Glenn Larsen, William Lumma, Magdalene Moran, Amy Ripka, Dennis Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20070004785
    Abstract: The invention provides novel compositions and compounds that inhibit CatSper channel activity, that preferentially inhibits sperm hyperactivity over sperm motility, or both. The compounds of the invention are useful as contraceptive agents that may be adminstered to males, females, or concurrently to both sexual partners. The invention further provides methods of conducting drug discovery business and of conducting a reproductive medicine business. The invention also provides methods of identifying compounds that modulate sperm hypermotility.
    Type: Application
    Filed: June 15, 2006
    Publication date: January 4, 2007
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Magdalene Moran
  • Publication number: 20060270688
    Abstract: The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
    Type: Application
    Filed: May 9, 2006
    Publication date: November 30, 2006
    Applicant: Hydra Biosciences, Inc.
    Inventors: Jayhong Chong, Christopher Fanger, Glenn Larsen, William Lumma, Magdalene Moran, Amy Ripka, Dennis Underwood, Manfred Weigele, Xiaoguang Zhen
  • Publication number: 20060257868
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: August 4, 2003
    Publication date: November 16, 2006
    Applicant: Children's Medical Center Corporation
    Inventors: Magdalene Moran, Jayhong Chong, Ian Ramsey, David Clapham
  • Publication number: 20060123497
    Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.
    Type: Application
    Filed: August 4, 2003
    Publication date: June 8, 2006
    Inventors: Magdalene Moran, Jayhong Chong, Ian Ramsey, David Clapham
  • Publication number: 20050202539
    Abstract: The present invention provides methods and compositions for expressing eukaryotic membrane proteins.
    Type: Application
    Filed: March 11, 2005
    Publication date: September 15, 2005
    Applicant: Hydra Biosciences
    Inventors: Jayhong Chong, Magdalene Moran, David Clapham